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Noninvasive amniotic fluid
sampling to establish PK of
azithromycin in pregnancy
PRESENTER:

Rupsa C. Boelig, MD MS
Department of Pharmacology
and Experimental Therapeutics
Sidney Kimmel Medical College,
Thomas Jefferson University
BACKGROUND: Pharmacokinetic studies to
guide dosing of azithromycin (AZ) for
pregnancy specific conditions, such as
preterm premature rupture of membranes
(PPROM), and data on accumulation of AZ in
fetal compartment are lacking
METHODS
•

Prospective study of 5 pregnant women
admitted with PPROM

•

1gram oral azithromycin dose one time
administered on admission

•

Amniotic fluid collected non-invasively
from underwear lining pads ad lib

•

LCMS/mass spectrometry used to quantify
AZ concentration

•

Luminex multiplex assay used to quantify
TNFa, IL-1a, IL-1B, IL-6, IL-8, IL-10.

•

Primary outcome: time/concentration
profile of AZ in AF

MAIN RESULTS
• Mean gestational age was 27.5 ±2.3wk and
BMI 32.8 ±6.2kg/m2
•

•

AZ successfully quantified in duplicate,
coefficient of variation 17%. The lower
limit of detection and quantitation was
found to be 1 ng/mL and 10 ng/mL,
respectively (Figure 1)
AZ trended down and was <60ng/mL after
day 3 (Figure 2)

Azithromycin persists in fetal
compartment for 7 days after single
maternal dose, but may not be at
adequate concentrations

Table 1: Azithromycin (AZ) concentration in amniotic
fluid 1-7 days after a single one gram oral azithromycin
maternal dose. There were no samples collected 0-24 hours
for any participants so that data is not available (N/A).
N= number of participants and n= total number of samples.
CV: coefficient of variation. IQR: interquartile range

Figure 1: Representative LCMS chromatogram from
a) Subject 4, b) Subject 5, and c) AZ-D3 internal standard

Figure 2: Azithromycin concentration in amniotic fluid following 1 gram oral maternal dose in
pregnant patients with preterm premature rupture of membranes.
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Figure 3: Azithromycin concentration was positively
correlated with IL-8 (r=0.38, p=0.03), IL-1a (r=0.39,
p=0.03), and IL-1b (r=0.36, p=0.04) in amniotic fluid.
Azithromycin concentration was not correlated with TNFa
(r=0.30, p=0.07), IL-6 (r= -0.06, p=0.75), or IL-10 (r=0.23,
p=0.2) concentration in amniotic fluid.
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